Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AMG chart


Full chart

AMG upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪131.10 B‬ EUR
Dividend yield (indicated)
3.36%
Price to earnings Ratio (TTM)
23.05
Basic EPS (TTM)
10.45 EUR
Net income (FY)
‪3.95 B‬ EUR
Revenue (FY)
‪32.10 B‬ EUR
Shares float
‪537.30 M‬
Beta (1Y)
0.42

Employees


Employees (FY)
‪28 K‬
Change (1Y)
‪+1.3 K‬ +4.87%
Revenue / Employee (1Y)
‪1.15 M‬ EUR
Net income / Employee (1Y)
‪141.10 K‬ EUR

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
ISIN
US0311621009
FIGI
BBG000DJ1RM8
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Check out other big names from the same industry as AMG.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AMG news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMG highest yielding bonds


AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
—
Maturity date
Jun 15, 2048
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
—
Maturity date
Jun 15, 2051
AMGN4984121
Amgen Inc. 2.3% 25-FEB-2031
Yield to maturity
—
Maturity date
Feb 25, 2031
AMGN.HG
Amgen Inc. 5.15% 15-NOV-2041
Yield to maturity
—
Maturity date
Nov 15, 2041
AMGN.GU
Amgen Inc. 6.9% 01-JUN-2038
Yield to maturity
—
Maturity date
Jun 1, 2038
AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
—
Maturity date
Apr 1, 2097
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
—
Maturity date
Jan 15, 2052
AMGN4368346
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
—
Maturity date
Jun 15, 2048
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
—
Maturity date
Aug 15, 2041
AMGN.GV
Amgen Inc. 6.4% 01-FEB-2039
Yield to maturity
—
Maturity date
Feb 1, 2039
AMGN4368348
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
—
Maturity date
Jun 15, 2051

See all AMG bonds 

Sparks


Curated watchlists where AMG is featured.

See all sparks 

Frequently Asked Questions


The current price of AMG is 241.30 EUR — it has decreased by −0.31% in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Amgen Inc. stocks are traded under the ticker AMG.
AMG stock has fallen by −1.15% compared to the previous week, the month change is a −6.33% fall, over the last year Amgen Inc. has showed a −18.90% decrease.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMG price has a max estimate of 345.72 EUR and a min estimate of 153.65 EUR. Watch AMG chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMG reached its all-time high on Aug 5, 2024 with the price of 319.40 EUR, and its all-time low was 25.40 EUR and was reached on Mar 20, 2008. View more price dynamics on AMG chart.
See other stocks reaching their highest and lowest prices.
AMG stock is 0.81% volatile and has beta coefficient of 0.42. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of ‪131.10 B‬, it has decreased by −0.81% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
AMG earnings for the last quarter are 5.11 EUR per share, whereas the estimation was 4.48 EUR resulting in a 13.99% surprise. The estimated earnings for the next quarter are 4.33 EUR per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to ‪7.79 B‬ EUR, despite the estimated figure of ‪7.59 B‬ EUR. In the next quarter, revenue is expected to reach ‪7.71 B‬ EUR.
AMG net income for the last quarter is ‪1.22 B‬ EUR, while the quarter before that showed ‪1.60 B‬ EUR of net income which accounts for −23.98% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMG dividends are paid quarterly. The last dividend per share was 2.03 EUR. As of today, Dividend Yield (TTM)% is 3.31%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 3.45% in 2024, and payout ratio reached 119.05%. The year before the numbers were 2.96% and 68.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 7, 2025, the company has ‪28 K‬ employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is ‪12.92 B‬ EUR, and current EBITDA margin is 41.84%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the neutral signal. See more of Amgen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.